153 related articles for article (PubMed ID: 12625872)
1. Binding and functional affinity of some newly synthesized phenethylamine and phenoxypropanolamine derivatives for their agonistic activity at recombinant human beta3-adrenoceptor.
Ahmed M; Hanaoka Y; Nagatomo T; Kiso T; Kakita T; Kurose H; Nagao T
J Pharm Pharmacol; 2003 Jan; 55(1):95-101. PubMed ID: 12625872
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
[TBL] [Abstract][Full Text] [Related]
3. Anti-obesity and anti-diabetic activities of a new beta3 adrenergic receptor agonist, (S)-(Z)-[4-[[1-[2-[(2-hydroxy-3-phenoxypropyl)]amino]ethyl]-1-propenyl] phenoxy] acetic acid ethanedioic acid (SWR-0342SA), in KK-Ay mice.
Kiso T; Namikawa T; Tokunaga T; Sawada K; Kakita T; Shogaki T; Ohtsubo Y
Biol Pharm Bull; 1999 Oct; 22(10):1073-8. PubMed ID: 10549858
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship studies of phenoxypropanolamine derivatives for beta 3-adrenergic activity.
Ahmed M; Hanaoka Y; Nagatomo T
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):112P-113P. PubMed ID: 12491799
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of pharmacological properties and selectivity of SWR-0315NA for beta3-adrenoceptors.
Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Nagatomo T
Biol Pharm Bull; 2004 May; 27(5):718-22. PubMed ID: 15133253
[TBL] [Abstract][Full Text] [Related]
6. The beta3-adrenoceptor agonist 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-phenyl]-benzenesulfonamide (L755507) and antagonist (S)-N-[4-[2-[[3-[3-(acetamidomethyl)phenoxy]-2-hydroxypropyl]amino]-ethyl]phenyl]benzenesulfonamide (L748337) activate different signaling pathways in Chinese hamster ovary-K1 cells stably expressing the human beta3-adrenoceptor.
Sato M; Hutchinson DS; Evans BA; Summers RJ
Mol Pharmacol; 2008 Nov; 74(5):1417-28. PubMed ID: 18684840
[TBL] [Abstract][Full Text] [Related]
7. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agonist for the treatment of preterm labor.
Croci T; Cecchi R; Marini P; Rouget C; Viviani N; Germain G; Guagnini F; Fradin Y; Descamps L; Pascal M; Advenier C; Breuiller-Fouché M; Leroy MJ; Bardou M
J Pharmacol Exp Ther; 2007 Jun; 321(3):1118-26. PubMed ID: 17351104
[TBL] [Abstract][Full Text] [Related]
9. Selectivity and potency of agonists for the three subtypes of cloned human beta-adrenoceptors expressed in Chinese hamster ovary cells.
Yanagisawa T; Sato T; Yamada H; Sukegawa J; Nunoki K
Tohoku J Exp Med; 2000 Nov; 192(3):181-93. PubMed ID: 11249148
[TBL] [Abstract][Full Text] [Related]
10. Evidence for pleiotropic signaling at the mouse beta3-adrenoceptor revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate].
Hutchinson DS; Sato M; Evans BA; Christopoulos A; Summers RJ
J Pharmacol Exp Ther; 2005 Mar; 312(3):1064-74. PubMed ID: 15574684
[TBL] [Abstract][Full Text] [Related]
11. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium.
Sarsero D; Molenaar P; Kaumann AJ
Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of SWR-0342SA, a beta3-selective agonist, with beta1- and beta3-adrenoceptor.
Ahmed M; Ishiguro M; Nagatomo T
Life Sci; 2006 Mar; 78(17):2019-23. PubMed ID: 16310810
[TBL] [Abstract][Full Text] [Related]
13. Agonist potency at the cloned human beta-3 adrenoceptor depends on receptor expression level and nature of assay.
Wilson S; Chambers JK; Park JE; Ladurner A; Cronk DW; Chapman CG; Kallender H; Browne MJ; Murphy GJ; Young PW
J Pharmacol Exp Ther; 1996 Oct; 279(1):214-21. PubMed ID: 8858996
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a secondary state of the human beta3-adrenoceptor.
Baker JG
Mol Pharmacol; 2005 Dec; 68(6):1645-55. PubMed ID: 16129733
[TBL] [Abstract][Full Text] [Related]
15. Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes.
Nisoli E; Tonello C; Landi M; Carruba MO
Mol Pharmacol; 1996 Jan; 49(1):7-14. PubMed ID: 8569714
[TBL] [Abstract][Full Text] [Related]
16. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog.
Hicks A; McCafferty GP; Riedel E; Aiyar N; Pullen M; Evans C; Luce TD; Coatney RW; Rivera GC; Westfall TD; Hieble JP
J Pharmacol Exp Ther; 2007 Oct; 323(1):202-9. PubMed ID: 17626794
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP-independent relaxation mediated by beta3-adrenoceptors on guinea pig gastrointestine.
Horinouchi T; Koike K
Eur J Pharmacol; 2002 May; 442(1-2):137-46. PubMed ID: 12020691
[TBL] [Abstract][Full Text] [Related]
18. Lack of evidence that nebivolol is a β₃-adrenoceptor agonist.
Frazier EP; Michel-Reher MB; van Loenen P; Sand C; Schneider T; Peters SL; Michel MC
Eur J Pharmacol; 2011 Mar; 654(1):86-91. PubMed ID: 21172342
[TBL] [Abstract][Full Text] [Related]
19. Agonist effects of zinterol at the mouse and human beta(3)-adrenoceptor.
Hutchinson DS; Chernogubova E; Sato M; Summers RJ; Bengtsson T
Naunyn Schmiedebergs Arch Pharmacol; 2006 May; 373(2):158-68. PubMed ID: 16601951
[TBL] [Abstract][Full Text] [Related]
20. Stereospecific synthesis and bio-activity of novel beta(3)-adrenoceptor agonists and inverse agonists.
Perrone MG; Santandrea E; Bleve L; Vitale P; Colabufo NA; Jockers R; Milazzo FM; Sciarroni AF; Scilimati A
Bioorg Med Chem; 2008 Mar; 16(5):2473-88. PubMed ID: 18083578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
